Doctor Efstratios Apostolou

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE, London (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries.

Presentation

Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries.

ESC 365 is supported by

novartis

Explore sponsored resources